Clinical Trial Results:
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Active
Controlled, Parallel Group, Multicenter Study to Assess the Safety and
Efficacy of 2 Fixed Dose Groups of TC-5214 (S-mecamylamine) as
Monotherapy Treatment in Patients with Major Depressive Disorder with
an Inadequate Response to Antidepressant Therapy
Summary
|
|
EudraCT number |
2010-023816-15 |
Trial protocol |
FI EE |
Global completion date |
01 Aug 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
09 Sep 2016
|
First version publication date |
09 Sep 2016
|
Other versions |
|
Summary report(s) |
RRF_D4131C00001 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.